These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11560190)

  • 1. Management of coronary heart disease risk factors and progression with calcium channel blockers.
    Pieper JA
    Pharmacotherapy; 2001 Sep; 21(9 Pt 2):195S-208S. PubMed ID: 11560190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers and coronary heart disease.
    Inzitari M; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
    Jeffers BW; Robbins J; Bhambri R; Wajsbrot D
    Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
    Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
    J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension control in the elderly with amlodipine.
    Pascual J
    Curr Med Res Opin; 2000; 16(1):33-6. PubMed ID: 16422032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
    Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amlodipine + candesartan on cardiovascular events in hypertensive patients with coronary artery disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study).
    Yamaguchi J; Hagiwara N; Ogawa H; Koyanagi R; Kasanuki H; Takagi A; Mori F; Nagashima M; Yagi M;
    Am J Cardiol; 2010 Sep; 106(6):819-24. PubMed ID: 20816122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B
    Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence.
    Mason RP
    Atherosclerosis; 2002 Dec; 165(2):191-9. PubMed ID: 12417269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine PREVENTS angina, not atherosclerosis.
    Williams C
    Pharmacotherapy; 2002 Mar; 22(3):400-1; discussion 401-2. PubMed ID: 11898898
    [No Abstract]   [Full Text] [Related]  

  • 16. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and JSH2009].
    Ebina T; Kimura K; Umemura S
    Clin Calcium; 2010 Jan; 20(1):16-22. PubMed ID: 20048429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?
    Doggrell SA
    Expert Opin Pharmacother; 2005 May; 6(5):831-4. PubMed ID: 15934908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
    Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
    Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
    Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
    J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.